Elevance Health Inc., FCFF calculation

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Shareholders’ net income	5,987)	6,025)	6,104)	4,572)	4,807)
Net (gain) loss attributable to noncontrolling interests	4)	(6)	(9)	—)	—)
Net noncash charges	2,605)	2,127)	1,076)	862)	1,348)
Changes in operating assets and liabilities	(535)	253)	1,193)	5,254)	(94)
Net cash provided by operating activities	8,061)	8,399)	8,364)	10,688)	6,061)
Interest paid, net of tax¹	802)	680)	632)	582)	606)
Purchases of property and equipment	(1,296)	(1,152)	(1,087)	(1,021)	(1,077)
Free cash flow to the firm (FCFF)	7,567)	7,927)	7,909)	10,249)	5,590)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

¹ See details »

Download chart

Item	Description	The company
FCFF	Free cash flow to the firm is the cash flow available to the Elevance Health Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.	Elevance Health Inc. FCFF increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.

Elevance Health Inc., interest paid, net of tax calculation

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Effective Income Tax Rate (EITR)
EITR¹	22.30%	22.50%	23.10%	26.70%	19.70%
Interest Paid, Net of Tax
Interest paid, before tax	1,032)	878)	822)	794)	755)
Less: Interest paid, tax²	230)	198)	190)	212)	149)
Interest paid, net of tax	802)	680)	632)	582)	606)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

¹ See details »

² 2023 Calculation
Interest paid, tax = Interest paid × EITR
= 1,032 × 22.30% = 230

Download chart

Elevance Health Inc., current EV/FCFF calculation, comparison to benchmarks

Selected Financial Data (US$ in millions)
Enterprise value (EV)	106,806)
Free cash flow to the firm (FCFF)	7,567)
Valuation Ratio
EV/FCFF	14.11
Benchmarks
EV/FCFF, Competitors¹
Abbott Laboratories	35.03
Cigna Group	10.72
CVS Health Corp.	11.24
Danaher Corp.	34.94
Humana Inc.	8.34
Intuitive Surgical Inc.	171.08
Medtronic PLC	24.33
UnitedHealth Group Inc.	16.63
EV/FCFF, Sector
Health Care Equipment & Services	18.84
EV/FCFF, Industry
Health Care	22.80

Based on: 10-K (reporting date: 2023-12-31).

¹ Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.

Elevance Health Inc., historical EV/FCFF calculation, comparison to benchmarks

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selected Financial Data (US$ in millions)
Enterprise value (EV)¹	107,367)	105,582)	100,728)	61,875)	71,186)
Free cash flow to the firm (FCFF)²	7,567)	7,927)	7,909)	10,249)	5,590)
Valuation Ratio
EV/FCFF³	14.19	13.32	12.74	6.04	12.73
Benchmarks
EV/FCFF, Competitors⁴
Abbott Laboratories	36.51	23.24	23.47	36.94	33.05
Cigna Group	10.44	13.38	14.17	9.16	10.24
CVS Health Corp.	11.96	10.00	10.30	9.42	12.30
Danaher Corp.	36.34	25.74	28.25	30.66	37.11
Humana Inc.	9.95	14.88	42.03	7.92	8.46
Intuitive Surgical Inc.	170.92	85.45	56.01	76.70	54.58
Medtronic PLC	26.54	20.32	33.84	21.43	22.07
UnitedHealth Group Inc.	17.59	19.30	22.21	15.82	17.51
EV/FCFF, Sector
Health Care Equipment & Services	19.66	18.05	20.42	15.95	17.63
EV/FCFF, Industry
Health Care	23.69	17.73	17.16	17.81	18.15

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

¹ See details »

² See details »

³ 2023 Calculation
EV/FCFF = EV ÷ FCFF
= 107,367 ÷ 7,567 = 14.19

⁴ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
EV/FCFF	Enterprise value to free cash flow to the firm is whole company valuation indicator.	Elevance Health Inc. EV/FCFF ratio increased from 2021 to 2022 and from 2022 to 2023.

Elevance Health Inc. (NYSE:ELV)

Enterprise Value to FCFF (EV/FCFF)

Free Cash Flow to The Firm (FCFF)

Interest Paid, Net of Tax

Enterprise Value to FCFF Ratio, Current

Enterprise Value to FCFF Ratio, Historical